BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38611058)

  • 1. Role of the Atypical MAPK ERK3 in Cancer Growth and Progression.
    Elkhadragy L; Myers A; Long W
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.
    Alshammari ES; Aljagthmi AA; Stacy AJ; Bottomley M; Shamma HN; Kadakia MP; Long W
    BMC Cancer; 2021 Feb; 21(1):155. PubMed ID: 33579235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.
    Elkhadragy L; Alsaran H; Morel M; Long W
    J Biol Chem; 2018 Oct; 293(42):16193-16205. PubMed ID: 30166347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.
    Elkhadragy L; Alsaran H; Long W
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.
    Chen M; Myers AK; Markey MP; Long W
    J Cell Physiol; 2019 Aug; 234(8):13220-13232. PubMed ID: 30569573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.
    Mathien S; Déléris P; Soulez M; Voisin L; Meloche S
    Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.
    Alsaran H; Elkhadragy L; Shakya A; Long W
    Sci Rep; 2017 Nov; 7(1):14979. PubMed ID: 29101390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.
    An HJ; Lee CJ; Lee GE; Choi Y; Jeung D; Chen W; Lee HS; Kang HC; Lee JY; Kim DJ; Choi JS; Cho ES; Choi JS; Cho YY
    Exp Mol Med; 2022 Jan; 54(1):35-46. PubMed ID: 35022544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.
    Long W; Foulds CE; Qin J; Liu J; Ding C; Lonard DM; Solis LM; Wistuba II; Qin J; Tsai SY; Tsai MJ; O'Malley BW
    J Clin Invest; 2012 May; 122(5):1869-80. PubMed ID: 22505454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.
    Elkhadragy L; Chen M; Miller K; Yang MH; Long W
    Mol Oncol; 2017 Feb; 11(2):194-207. PubMed ID: 28079973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3.
    Hansen CA; Bartek J; Jensen S
    Cell Cycle; 2008 Feb; 7(3):325-34. PubMed ID: 18235225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.
    Al-Mahdi R; Babteen N; Thillai K; Holt M; Johansen B; Wetting HL; Seternes OM; Wells CM
    Cell Adh Migr; 2015; 9(6):483-94. PubMed ID: 26588708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.
    De la Mota-Peynado A; Chernoff J; Beeser A
    J Biol Chem; 2011 Apr; 286(15):13603-11. PubMed ID: 21317288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3.
    Schröder M; Filippakopoulos P; Schwalm MP; Ferrer CA; Drewry DH; Knapp S; Chaikuad A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4.
    Aberg E; Perander M; Johansen B; Julien C; Meloche S; Keyse SM; Seternes OM
    J Biol Chem; 2006 Nov; 281(46):35499-510. PubMed ID: 16971392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catalytic activity of the mitogen-activated protein kinase extracellular signal-regulated kinase 3 is required to sustain CD4+ CD8+ thymocyte survival.
    Marquis M; Daudelin JF; Boulet S; Sirois J; Crain K; Mathien S; Turgeon B; Rousseau J; Meloche S; Labrecque N
    Mol Cell Biol; 2014 Sep; 34(18):3374-87. PubMed ID: 25002529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
    Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM
    EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of ERK1/2 and ERK3 during normal rat fetal lung development.
    Kling DE; Brandon KL; Sollinger CA; Cavicchio AJ; Ge Q; Kinane TB; Donahoe PK; Schnitzer JJ
    Anat Embryol (Berl); 2006 Mar; 211(2):139-53. PubMed ID: 16374608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.
    Déléris P; Trost M; Topisirovic I; Tanguay PL; Borden KL; Thibault P; Meloche S
    J Biol Chem; 2011 Feb; 286(8):6470-8. PubMed ID: 21177870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.
    Cargnello M; Roux PP
    Microbiol Mol Biol Rev; 2011 Mar; 75(1):50-83. PubMed ID: 21372320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.